Myofunctional Therapy App for Severe Apnea–Hypopnea Sleep Obstructive Syndrome: Pilot Randomized Controlled Trial
Publicaciones de socios | Comisión de investigación
Otras publicaciones
Fecha de publicación
09/11/2020
Autores
Carlos O’Connor-Reina1,2*, MD, PhD ; Jose Maria Ignacio Garcia3,4*, MD, PhD ; Elisa Rodriguez Ruiz3*, BS, MS ; Maria Del Carmen Morillo Dominguez3*, MD ; Victoria Ignacio Barrios3,4*, MD ; Peter Baptista Jardin5*, MD, PhD ; Juan Carlos Casado Morente1,2*, MD, PhD ; Maria Teresa Garcia Iriarte6*, MD, PhD ; Guillermo Plaza7,8*, MD, PhD
Área de la especialidad
Datos bibliográficos
O’Connor-Reina C, Ignacio Garcia JM, Rodriguez Ruiz E, Morillo Dominguez MDC, Ignacio Barrios V, Baptista Jardin P, Casado Morente JC, Garcia Iriarte MT, Plaza G
Myofunctional Therapy App for Severe Apnea–Hypopnea Sleep Obstructive Syndrome: Pilot Randomized Controlled Trial
JMIR Mhealth Uhealth 2020;8(11):e23123
URL: https://mhealth.jmir.org/2020/11/e23123
DOI: 10.2196/23123
PMID: 33093013
Abstract
Background: Myofunctional therapy has demonstrated efficacy in treating sleep-disordered breathing. We assessed the clinical use of a new mobile health (mHealth) app that uses a smartphone to teach patients with severe obstructive sleep apnea–hypopnea syndrome (OSAHS) to perform oropharyngeal exercises.
Objective: We conducted a pilot randomized trial to evaluate the effects of the app in patients with severe OSAHS.
Methods: Forty patients with severe OSAHS (apnea–hypoxia index [AHI]>30) were